The Latest in Conference Coverage

Multiple sclerosis has a misdiagnosis problem

June 15, 2023

Multiple Sclerosis

No apparent drug interaction with ozanimod and antidepressants

June 13, 2023

Multiple Sclerosis

‘Strikingly positive’ effect of novel MS agent

June 9, 2023

Multiple Sclerosis

MS relapse rates similar between anti-CD20 mAbs and switching to fumarates

June 9, 2023

Multiple Sclerosis

Shingles infection rates higher in patients with MS

June 9, 2023

Multiple Sclerosis

Ozanimod for relapsing MS shows long-term safety, efficacy with age differences

June 8, 2023

Multiple Sclerosis

Multiple changes in NMOSD treatment for nonmedical reasons tied to poorer outcomes

June 6, 2023

Multiple Sclerosis

Racial, ethnic disparities persist in access to MS care

June 6, 2023

Multiple Sclerosis

Long-term freedom from NMOSD relapse with satralizumab

June 5, 2023

Multiple Sclerosis

Mindfulness-based stress reduction program benefits MS patients

June 5, 2023

Multiple Sclerosis

Teriflunomide delays MS symptoms in radiologically isolated syndrome

May 5, 2023

Multiple Sclerosis

High-dose vitamin D and MS relapse: New phase 3 data

May 1, 2023

Multiple Sclerosis

Machine learning can predict primary progressive MS progression

April 27, 2023

Multiple Sclerosis

Mediterranean diet improves cognition in MS

April 19, 2023

Multiple Sclerosis

Physical activity is a growing priority for patients with MS

March 8, 2023

Multiple Sclerosis